Announcement on voluntary disclosure of the qualifications obtained by the company and its subsidiaries from July to September 2024
Announcement on the expiration of the holdings reduction plan for shareholders holding 5% or more of the shares and the results of reducing their holdings
Anbiping Investor Relations Activity Record Form (September 12, 2024)
Anbiping Investor Relations Activity Record Form (September 3, 2024)
Resolutions of the Fourth Meeting of the Fourth Special Meeting of Independent Directors of the Board of Directors
Announcement on the acquisition of minority shareholders\' shares in holding subsidiaries and related transactions
Announcement on holding the 2024 semi-annual results briefing
Special inspection report of Minsheng Securities Co., Ltd. on the storage and use of funds raised by Guangzhou Anbiping Pharmaceutical Technology Co., Ltd. for the 2024 semi-year
2024 Semi-Annual Report
Announcement on the use of own funds for cash management
Special report on the storage and actual use of funds raised in the 2024 semi-year
Opinions of Minsheng Securities Co., Ltd. on the verification of the use of temporarily idle funds raised by Guangzhou Anbiping Pharmaceutical Technology Co., Ltd. for cash management
Notice on Using Temporarily Idle Raised Funds for Cash Management
Semi-annual Evaluation Report on the 2024 “Improve Quality, Increase Efficiency, and Focus on Return” Special Action Plan
2024 Semi-Annual Report Summary
Announcement of Resolutions of the Fourth Meeting of the Fourth Board of Supervisors
Announcement on voluntary disclosure of the qualification status of the company and its subsidiaries from April to June 2024.
Announcement of Shareholding Reduction by Shareholder
Simplified Equity Change Report
Notice of Equity Change: Shareholders holding more than 5% of the shares will reduce their shareholdings to 5%.
No Data
No Data